GLP-1 Weight Loss
Retatrutide (Triple G Agonist)
Reconstitution & Dosing Guide
Next-generation tri-agonist (GLP-1, GIP, and Glucagon receptors) driving highest recorded clinical weight reduction.
Standard Vial Size:10 mg
Recommended BAC Water:2.0 mL
Refrigerated Stability:28 Days
Elimination Half-Life:144 Hours
Standard Titration & Syringe Unit Chart (10mg Vial + 2mL Water)
Concentration produces exactly 5.00 mg/mL (5,000 mcg/mL).
| Protocol Step / Dose | Target (mcg) | U-100 Syringe Units | Total Doses |
|---|---|---|---|
| 1.0 mg (Starting Dose) | 1000 mcg | 20.0 Units | 10 doses |
| 2.0 mg (Titration 1) | 2000 mcg | 40.0 Units | 5 doses |
| 4.0 mg (Target Therapeutic) | 4000 mcg | 80.0 Units | 2 doses |
| 8.0 mg (High) | 8000 mcg | 160.0 Units | 1 doses |
| 12.0 mg (Max Clinical Trial) | 12000 mcg | 240.0 Units | 0 doses |
Mixing & Handling Protocol
Store lyophilized powder frozen (-20°C) until reconstitution. Reconstitute with 2.0 mL BAC water.
Initial Protocol Target (1000 mcg)
20.0UNITS
Draw to the 20.0-unit mark on a standard 1.0 mL U-100 syringe.
Yields 10 complete doses per vial.Precision Syringe GaugeU-100 Standard Insulin Barrel
20.0 Units(20% Capacity)
0
10
20
30
40
50
60
70
80
90
100
◄ Luer Needle HubAlign black stopper edge to 20.0 linePlunger Flange ►
Advertisement & Sponsored Resource
High-RPM Health Sponsorship PlacementTargeting GLP-1 & Longevity Patient Audience